TRUST CO OF VERMONT - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 228 filers reported holding SORRENTO THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.

Quarter-by-quarter ownership
TRUST CO OF VERMONT ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$19
-74.0%
2040.0%0.00%
Q2 2023$730.0%2040.0%0.00%
Q1 2023$73
-59.7%
2040.0%0.00%
Q4 2022$1812040.0%0.00%
Q3 2022$02040.0%0.00%
Q2 2022$0
-100.0%
2040.0%0.00%
Q4 2021$1,000
-50.0%
2040.0%0.00%
Q2 2021$2,0000.0%2040.0%0.00%
Q1 2021$2,000
+100.0%
2040.0%0.00%
Q4 2020$1,000
-50.0%
2040.0%0.00%
Q3 2020$2,0002040.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 15,001$1,4100.00%
KLCM Advisors, Inc. 20,000$1,8800.00%
AlphaMark Advisors, LLC 3,135$00.00%
TRUST CO OF VERMONT 204$190.00%
SlateStone Wealth, LLC 30,866$30.00%
Coppell Advisory Solutions LLC 100$890.00%
Highlander Capital Management, LLC 1,200$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Russell Investments Group, Ltd. 266$250.00%
OGOREK ANTHONY JOSEPH /NY/ /ADV 3,600$00.00%
View complete list of SORRENTO THERAPEUTICS INC shareholders